Clinical Observation on Xiongbi Prescription No.3 for Treatment of Angina Pectoris after Percutaneous Coronary Intervention
Abstract：Objective To investigate the clinical efficacy ofXiongbiPrescription No.3 for treatment of angina pectoris afterper-cutaneous coronary intervention(PCI) .Me thods S ixty two cases w ith angina afterPCIwere random ly divided into control group ( n= 31) treated w ith oral isosorbide mononitrate and treatment group ( n = 31) treated w ith Xiongbi Prescription No.3 for four weeks .The clinical efficacy was observed and compared. Results The clinical efficacy and ECG improvement of the treatment group were superior to that in controlgroup.There was no significantdifferences in adverse reactions .Conclusion Xiongbifang Pre-scription No.3 is effective for angina afterPCI and no significant adverse reactions were observed.
Keywords：coronary heartdiseasepercutaneous coronary interventionanginaXiongbiPrescriptionNo.3
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 1293-1295 )